About Amgen (AMGN)
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis... Read more
- USD270.66
- USD273.48
- USD265.66
- USD346.85
- -8.70%
- 34.1B
- 3.33M
- 2.77M
- 151.2B
- 253.30
- -15.00%
- 12.80%
Stock News
1 hour ago
Stock-market bulls face inflation test this week, but trade talks may set the tone
MarketWatch
4 hours ago
Adtalem Global Education: A Picks-And-Shovels Play On The U.S. Healthcare Labor Crisis
SeekingAlpha
5 hours ago
The Real Brokerage Inc. 2025 Q1 - Results - Earnings Call Presentation
SeekingAlpha
5 hours ago
Invesco Rising Dividends Fund Q1 2025 Commentary
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
